Stereotactic body radiation therapy for the treatment of oligoprogression on androgen receptor targeted therapy in castration-resistant prostate cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Thu-Cuc,Nguyen ^[1] ; Ravneet,Bajwa ^[2] ; Shahla,Bari ^[3] ; Azka,Ali ^[3] ; William Paul,Skelton ^[3] ; Roland-Austin,Federico ^[3] ; Rohit,Bishnoi ^[3] ; Justin W,Wray ^[4] ; Robert A,Zlotecki ^[4] ; Long H,Dang ^[2] ; Jameel,Muzaffar ^[2]

作者单位： Department of Internal Medicine, University of Central Florida, Orlando, FL, USA. ^[1] Division of Hematology and Oncology, Department of Internal Medicine, University of Florida, Gainesville, FL, USA. ^[2] Department of Internal Medicine, University of Florida, Gainesville, FL, USA. ^[3] Department of Radiation Oncology, University of Florida, Gainesville, FL, USA. ^[4]

DOI 10.1093/omcr/omx078

PMID 29340160

发布时间 2024-06-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Oxford medical case reports

2018年2018卷1期

omx078页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Stereotactic body radiation therapy for the treatment of oligoprogression on androgen receptor targeted therapy in castration-resistant prostate cancer.

Oxford medical case reports

相似文献

Oxford medical case reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Stereotactic body radiation therapy for the treatment of oligoprogression on androgen receptor targeted therapy in castration-resistant prostate cancer.

Oxford medical case reports

相似文献

Oxford medical case reports

相关期刊

检索历史清除